Element Labs
Series A in 2025
Element Labs develops AI processors for inference.
Home First Finance
Post in 2025
Home First Finance Company is an affordable housing finance company focused on providing housing loans to first-time buyers of affordable homes, specifically those priced between Rs. 5 lakhs and Rs. 30 lakhs. The company aims to serve customers who face challenges in obtaining loans from traditional banks and housing finance companies. In addition to housing loans, Home First Finance also offers loans for purchasing commercial properties, loans against property, and construction finance. Recognizing the complexities of the home buying process, the company assists consumers by addressing their concerns related to financing, eligibility, documentation, and ownership, guiding them through their journey towards homeownership.
Nuro, Inc. is a technology company based in Mountain View, California, that specializes in the development of self-driving vehicles specifically designed for local goods transportation. Incorporated in 2016, Nuro aims to transform local commerce through its fleet of fully autonomous, electric vehicles that facilitate the delivery of a wide range of products, including food and pharmaceuticals. By enabling retailers to efficiently and safely deliver goods to customers, Nuro enhances the convenience of local commerce and meets the growing demand for autonomous delivery solutions.
Plaid
Venture Round in 2025
Plaid Inc. is a technology company that facilitates the connection between consumers' bank accounts and applications, aiming to democratize financial services through advanced technological solutions. Founded in 2012 and headquartered in San Francisco, it provides a comprehensive suite of APIs that enable developers to create financial products connecting users with traditional financial institutions. Plaid's offerings include tools for accessing transaction history and balance data, authenticating bank accounts for payments, verifying identities, and confirming real-time account balances and income. These products support various applications in personal finances, consumer payments, lending, banking, and business finance. With a focus on enhancing both consumer experiences and developer capabilities, Plaid serves a diverse range of clients, including Fortune 50 companies, positioning itself as a vital infrastructure provider in the digital financial landscape.
Runway is an applied AI research company established in 2024, specializing in developing innovative tools that integrate artificial intelligence into creative processes. The company offers a video editing platform designed for professionals in art, entertainment, and design. Its technology leverages original image and video creation methods, allowing users to manipulate and edit content intuitively using text inputs. This approach simplifies the video creation process for artists, designers, and filmmakers, enabling them to express their creativity more effectively. Runway's mission is to enhance human creativity through advanced AI capabilities, facilitating seamless interactions between technology and artistic expression.
Retym is a semiconductor startup focused on developing innovative technologies for the data center and telecommunications sectors. The company's expertise lies in semiconductor technology, specifically designed to enhance optical communications and support deep learning and artificial intelligence applications. With a team comprising ASIC designers and optical communications specialists, Retym aims to identify and create disruptive solutions that advance optical networking and digital signal processing technology. By doing so, Retym seeks to enable businesses to construct next-generation data centers, thereby transforming industry standards and capabilities.
HeartFlow
Convertible Note in 2025
HeartFlow Inc., established in 2007 and headquartered in Redwood City, California, specializes in non-invasive coronary artery detection solutions. The company's flagship product, HeartFlow Analysis, employs artificial intelligence to generate a personalized 3D model of the heart using standard CT scan data. This enables clinicians worldwide to assess the impact of blockages on blood flow and determine optimal patient treatment, thereby reducing unnecessary invasive testing. HeartFlow operates additional offices in Portland (Oregon), Austin (Texas), London (UK), and Tokyo (Japan).
Capital Markets Gateway
Series C in 2025
Capital Markets Gateway Inc. is a financial technology firm that specializes in modernizing the equity capital markets. Based in Chicago, Illinois, with additional locations in New York and Seattle, CMG offers a platform that provides real-time information and analytics to investors, underwriters, and issuers. Founded in 2015 and officially launched in 2017 by a team of experienced professionals, the platform enhances transparency and workflow efficiencies in capital raising activities. It enables users to monitor the capital raising landscape, conduct due diligence, and make informed investment decisions while facilitating collaboration between stakeholders. Currently, CMG's platform is utilized by over 100 buy-side firms and 10 investment banks, supporting a substantial amount of assets under management.
Celestial AI
Series C in 2025
Celestial AI is a prominent artificial intelligence company that provides an advanced platform for users to efficiently create images, text, and presentations. Utilizing cutting-edge computer vision algorithms and natural language processing, the platform produces high-quality visual and textual content. Its intuitive design, combined with innovative features, facilitates easy content creation. Moreover, Celestial AI emphasizes intelligent data integration and prioritizes security, ensuring that users achieve impressive and reliable results.
Anthropic
Series E in 2025
Anthropic is an artificial intelligence research company dedicated to enhancing the safety and reliability of AI systems. The firm focuses on developing large-scale AI models that are interpretable, steerable, and aligned with human values. Its research encompasses various areas, including natural language processing, human feedback, scaling laws, reinforcement learning, and code generation. The company aims to produce AI systems that prioritize transparency and safety, enabling clients to better understand both the opportunities and risks associated with artificial intelligence. Anthropic's initial product, Claude, serves as an AI assistant designed for a range of tasks, reflecting the company's commitment to creating trustworthy AI solutions.
Amaero International
Post in 2025
Amaero International Ltd is an Australian company that specializes in the manufacturing of large format complex metal components through laser-based additive manufacturing processes. Founded in 2013 and headquartered in Notting Hill, the company utilizes advanced technologies such as gas atomization and hot isostatic pressing to produce high-temperature powder metals and specialty alloys, including refractory and titanium powders. Amaero serves a diverse range of sectors, including aviation, defense, aerospace, energy, and medical, while also catering to the tool and die industries. Its offerings encompass research and development, contract manufacturing, design and prototyping, and the sale of 3D printing equipment and consumables. Additionally, Amaero has established a strategic partnership with the University of Adelaide to advance additive manufacturing in South Australia.
Saluda Medical
Venture Round in 2025
Saluda Medical Pty Ltd. is a medical device company specializing in the development of neuromodulation technologies for chronic neurological conditions. Founded in 2010 and based in Artarmon, Australia, with additional offices in the United States and the United Kingdom, Saluda Medical focuses on its innovative Evoke system. This investigational device employs a closed-loop spinal cord stimulation approach that continuously monitors the spinal cord's response to stimulation and adjusts treatment in real-time to optimize patient outcomes. By utilizing a unique dose-control platform, Saluda Medical aims to customize therapy based on individual neural responses, thereby improving the management of chronic pain, particularly in patients suffering from conditions such as neuropathic pain and chronic back pain.
Tenstorrent
Series D in 2024
Tenstorrent Inc. is a technology company based in Toronto, Canada, with an additional office in Austin, Texas, founded in 2016. The company specializes in the development and manufacturing of application-specific integrated circuits (ASICs) tailored for machine learning and data processing tasks. Its hardware architecture is designed to support a range of applications, from battery-powered Internet of Things (IoT) devices to large-scale cloud servers, providing scalable solutions for deep learning. Tenstorrent's offerings enable developers and researchers in the artificial intelligence sector to enhance computational performance and adapt algorithms effectively, positioning the company as a key player in advancing AI technology.
Boosted.ai
Venture Round in 2024
Boosted.ai is an artificial intelligence company focused on improving portfolio management for the financial industry through distributed machine learning. Its flagship platform, Boosted Insights, enables portfolio managers to utilize advanced quantitative investing techniques without the need for coding or a data science background. The company develops machine learning software that enhances the investment decision-making process by conducting deep analyses of market data. By automating and simplifying complex tasks, Boosted.ai makes sophisticated investment tools accessible to all investment professionals, empowering them to achieve higher returns.
Oura is a Finnish company that specializes in the development of a smart wellness ring designed to monitor and track various biometric data related to health and well-being. The ring incorporates advanced sensors to measure key metrics such as heart rate, sleep cycles, and activity levels, providing users with insights into their physiological and behavioral responses to sleep, rest, and recovery. This data is accessible through the accompanying Oura application, which enables users to understand their overall health status and make informed lifestyle choices. Oura operates within the health and wellness industry, focusing on enhancing the user's understanding of their body and promoting better health outcomes.
CoreWeave
Secondary Market in 2024
CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.
BETA Technologies
Series C in 2024
BETA Technologies is an electric aerospace company focused on developing electric aircraft and advanced flight control systems aimed at promoting clean aviation technology. The company designs a self-sufficient ecosystem of electric vertical takeoff and landing (eVTOL) aircraft that meets the transportation needs of people and goods while adhering to environmental principles. BETA's technology encompasses all-electric aircraft and a comprehensive charging infrastructure to support various electric vehicles, enhancing the efficiency and sustainability of transportation. The company also offers training programs for pilots and maintenance personnel, serving clients in cargo, passenger, and emergency response sectors, thereby enabling more efficient, cleaner, and faster transportation solutions.
Crusoe Energy Systems
Series D in 2024
Crusoe Energy Systems Inc., based in Denver, Colorado, develops innovative technology and solutions aimed at addressing operational, environmental, and regulatory challenges in the oil and gas sector. Founded in 2018, the company specializes in its Digital Flare Mitigation solution, which allows upstream operators without pipeline access to convert wasted natural gas into electricity for energy-intensive computing. This service not only helps oil and gas producers reduce routine flaring of natural gas but also assists them in achieving regulatory compliance and maintaining production levels amid increasing regulations and pipeline constraints. Crusoe Energy Systems is committed to creating solutions that benefit the environment, local communities, and energy producers alike.
Lightmatter
Series D in 2024
Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in AI hardware development. The company pioneers integrated optical technology to create silicon chips that process data using light signals instead of electrical ones. This innovation aims to significantly accelerate AI computations, particularly in neural networks, while reducing power consumption. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications.
Wolfspeed is a leading manufacturer specializing in wide bandgap semiconductors, particularly silicon carbide (SiC) and gallium nitride (GaN) materials and devices. The company plays a crucial role in the transformation of the semiconductor industry, supporting the transition to electric vehicles, the deployment of faster 5G networks, and advancements in renewable energy and energy storage systems. Wolfspeed offers a range of products designed for power and radio-frequency applications, including use in transportation, power supplies, inverters, and wireless systems. With a workforce of over 550 skilled employees, the company boasts a robust intellectual property portfolio of approximately 2,000 patents and patent applications. Its operations are primarily based in Europe, with additional revenue derived from the United States, China, Hong Kong, and other regions.
City Therapeutics
Series A in 2024
City Therapeutics is a biopharmaceutical company specializing in the development of next-generation small-interfering RNAs (siRNAs) to enhance RNA interference (RNAi) therapies. The company's pipeline comprises innovative RNAi therapeutics targeting diverse disease indications. City Therapeutics aims to improve and expand RNAi technology to achieve better patient outcomes, led by a team of experienced scientists and industry professionals committed to advancing the field of RNA interference.
Triveni Bio
Series B in 2024
Triveni Bio is a biotechnology company specializing in the development of novel antibody therapies for immunological and inflammatory disorders. The company employs a genetics-driven precision medicine approach to identify patients most likely to respond to its treatments, aiming to accelerate drug development and improve the effectiveness and safety of therapies.
OpenAI
Venture Round in 2024
OpenAI is an artificial intelligence research and deployment company focused on developing machine learning technologies that aim to create safe artificial general intelligence for the benefit of all users. The company engages in projects related to autonomous learning and task performance across various industries, including technology, healthcare, and education. OpenAI's platform directs artificial intelligence applications and is involved in policy work, education, and outreach, enabling clients to enhance their skills and knowledge while leveraging autonomous systems that can surpass human performance in economically valuable tasks.
PNB Housing Finance
Post in 2024
PNB Housing Finance Limited is a housing finance company based in New Delhi, India, established in 1988. The company specializes in providing a variety of loans, including housing loans for the purchase, construction, repair, and renovation of residential and commercial properties. It also offers loans against property, loans for the purchase of residential plots, and financing for commercial spaces. PNB Housing Finance caters to different customer segments, including non-resident Indians and individuals from economically weaker sections and lower to middle-income groups through various schemes. In addition to home loans, the company provides non-home loans, such as mortgage loans for residential and commercial properties, lease rental discounting loans, and financing for real estate developers. PNB Housing Finance generates revenue primarily through interest income and fees from its diverse lending services.
Anduril Industries
Series F in 2024
Anduril Industries, Inc. is a defense technology company that designs, manufactures, and deploys advanced hardware and software products to address complex national security challenges faced by the United States and its allies. Founded in 2017 and headquartered in Irvine, California, with additional offices in Washington, D.C., and Seattle, the company employs top technical talent to create innovative solutions. Its offerings include the Lattice Platform, which integrates artificial intelligence, computer vision, and machine learning to provide a cohesive operational picture; the Sentry Tower, which collects data across the electromagnetic spectrum; and the Ghost sUAS, a man-portable unmanned aerial system capable of performing various missions autonomously. Additionally, Anduril develops the Anvil sUAS, designed for precise drone threat interception while providing visual feedback for human operators. Through its cutting-edge technology, Anduril aims to enhance defense capabilities and support frontline personnel in safeguarding national interests.
Applied Intuition
Secondary Market in 2024
Applied Intuition, Inc. is a company that creates software infrastructure to facilitate the safe development, testing, and deployment of autonomous vehicles at scale. Founded in 2017 and headquartered in Sunnyvale, California, the company also maintains offices in Silicon Valley and Detroit, Michigan. Its advanced simulation infrastructure software offers a comprehensive suite of products focused on simulation and analytics, enabling automotive industries to thoroughly test and expedite the development of their autonomous vehicle technologies. By providing sophisticated tools designed for scalability, Applied Intuition supports the automotive sector in navigating the complexities of autonomous vehicle deployment effectively.
Waymo is a self-driving technology company focused on enhancing mobility by creating safe and efficient transportation solutions. Established from advancements in Google's research since 2009, Waymo aims to improve the movement of people and goods through its innovative software and sensor technology. In 2015, the company marked a significant milestone by conducting the world's first fully autonomous trip on public roads in a vehicle devoid of traditional driving controls. Waymo continually refines its technology through extensive simulation testing, accumulating over one billion miles of virtual testing annually, while its autonomous vehicles have logged more than two million miles on public roads in four U.S. cities. By employing integrated sensors and artificial intelligence, Waymo's technology is designed to detect various obstacles such as pedestrians, cyclists, and road conditions, ensuring a safe and convenient on-demand travel experience for users.
Frore Systems
Series C in 2024
Frore Systems is a technology company based in San Jose, California, specializing in thermal management solutions for consumer devices. The company develops advanced cooling chips, specifically the AirJet® Mini and AirJet® Pro, which utilize piezoelectric MEMS technology to provide efficient and silent heat dissipation. These active cooling solutions significantly enhance device performance by outperforming traditional fan-based systems. With additional offices in Taiwan and South Korea, Frore Systems is positioned to impact the computing industry by enabling manufacturers to improve the thermal efficiency and performance of their devices.
CoreWeave
Series C in 2024
CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.
PSP Projects Ltd is a multidisciplinary construction company based in India, specializing in a wide range of construction and allied services. The company focuses on various sectors, including industrial, institutional, government, government residential, and residential projects. PSP Projects operates within a single segment of construction project activities, offering comprehensive services that cover the entire construction value chain. These services range from initial planning and design to actual construction and post-construction activities, catering to both private and public sector enterprises. The company's operations are primarily concentrated in India, where it generates its revenue.
Vodafone Idea
Post in 2024
Vodafone Idea is a prominent Indian telecommunications operator that offers comprehensive voice and data services across the country. Established through the merger of Vodafone India and Idea Cellular, the company primarily focuses on mobility services, which account for the majority of its revenue. It operates a vast telecommunications infrastructure, including fiber networks and mobile towers, to support its service offerings. Vodafone Idea primarily generates its revenue from the Indian market, positioning itself as a key player in the country's telecommunications sector. The company's operations encompass various aspects of information technology and telecommunications, catering to a diverse customer base.
SiMa Technologies, Inc. specializes in developing machine learning technology for embedded systems, offering a comprehensive machine learning system-on-chip (MLSoC) platform. Founded in 2018 and headquartered in San Jose, California, the company focuses on delivering high-performance machine learning capabilities with low power consumption. Its MLSoC enables seamless deployment and scaling of machine learning applications at the edge, enhancing performance and energy efficiency for various use cases, including computer vision and generative AI. The platform supports diverse frameworks, models, and sensors, ensuring flexibility and adaptability for customers. Additionally, SiMa's solutions incorporate security features, such as threat detection, to safeguard against potential cyber risks, thereby providing a robust environment for embedded edge applications.
MMI S.r.l. is an Italian company that specializes in the manufacture and development of advanced micro instruments designed for surgical interventions. Founded in 2015 and based in Calci, Italy, MMI focuses on creating wristed micro instruments and their associated fabrication processes. The company also offers a proprietary robotic platform that enhances the capabilities of these instruments, facilitating complex reconstruction procedures following traumatic injuries and tumor removals in areas such as the breast, head, and bones. MMI aims to support surgeons globally by providing innovative tools that improve surgical outcomes while also reducing costs for patients and healthcare systems.
Axis Bank, established in 1994 and headquartered in Mumbai, India, is the third largest private sector bank in the country. The bank offers a wide range of financial products and services, including personal loans, car loans, savings accounts, credit cards, education loans, trade and forex services, and internet banking. It has expanded its international presence with eight offices located in key global financial centers, including Singapore and Dubai, and a subsidiary in London. These international offices primarily focus on corporate lending, trade finance, syndication, investment banking, and liability businesses. Over the years, Axis Bank has shown consistent growth and stable asset quality, positioning itself as a significant player in the Indian banking sector.
VAST Data
Series E in 2023
VAST Data, Inc. is a technology company that specializes in developing innovative data storage solutions. Headquartered in New York, with additional offices in San Jose, California, the company offers a universal storage platform that utilizes Intel’s Optane SSDs as a cache for data stored on quad-level cell (QLC) SSDs. VAST Data's solutions cater to various sectors, including animation and visual effects, deep learning, life sciences, media and broadcasting, and enterprise backup and recovery. The platform is designed to enhance productivity, streamline data management, and accelerate time-to-insight for workload-intensive applications, making it particularly valuable for AI-driven organizations. Founded in 2016, VAST Data has rapidly established itself as a leading player in the data infrastructure market.
CoreWeave
Secondary Market in 2023
CoreWeave is a company that specializes in developing a cloud infrastructure platform aimed at providing powerful computing resources for artificial intelligence/machine learning (AI/ML) projects and other initiatives. Their platform features a specialized GPU cloud system designed to accelerate workflows by matching the complexity of models, allowing clients to scale efficiently and adapt to rapidly changing compute requirements. This enables clients to design and innovate with various types of compute resources tailored to their specific needs.
Zomato is a global online platform that connects over 55 million users with restaurants across 24 countries. It offers a comprehensive restaurant guide, enabling users to discover, rate, and review eateries, as well as order meals for delivery or table reservations. The company also provides advertising and ingredient supply services to its restaurant partners.
IperionX is an American company focused on developing sustainable supply chains for titanium and critical materials. Utilizing patented technologies, it produces high-performance titanium alloys from both titanium minerals and scrap, aiming to reduce energy consumption, costs, and carbon emissions. The company operates a pilot facility in Utah, where it creates titanium metal powders from recycled materials. IperionX also owns the Titan Project, a significant mineral resource in Tennessee that encompasses over 11,000 acres rich in titanium, rare earth elements, silica sand, and zircon. Its products are vital for advanced industries, including aerospace, defense, electric vehicles, and additive manufacturing, where sustainability and low carbon intensity are increasingly important.
SHINE Technologies
Convertible Note in 2023
SHINE Technologies, LLC is a medical technology company that specializes in the production and supply of medical tracers and cancer treatment elements. It primarily manufactures and distributes molybdenum-99 (moly-99), a key isotope used in the diagnosis and staging of various diseases, including cancer and heart disease. Additionally, SHINE offers iodine-131 and iodine-125 for treating thyroid cancer and other abnormal thyroid conditions, as well as for diagnosing liver function, kidney blood flow, and urinary tract obstruction. The company also provides xenon-133 for evaluating lung function and blood flow, particularly in the brain. SHINE's products are used extensively in the United States and internationally. Founded in 2010, the company is headquartered in Janesville, Wisconsin, with an additional office in Alkmaar, the Netherlands.
AgomAb Therapeutics
Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.
Evozyne, LLC is a biotechnology company based in Chicago, Illinois, that specializes in protein design and molecular engineering. Founded in 2020, Evozyne focuses on the discovery and development of therapeutic solutions by harnessing generative AI to create novel proteins with advanced functionality. The company operates multiple business units, including those dedicated to industrial applications, agriculture, energy, biopharmaceuticals, and environmental solutions. Its innovative platform utilizes data-driven models to understand protein folding, function, and the evolvability of synthetic proteins, allowing it to provide customized protein solutions to address complex human and societal challenges.
Generate Biomedicines
Series C in 2023
Generate Biomedicines, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on developing innovative therapeutics through its pioneering platform in Generative Biology. Established in 2018, the company utilizes machine learning to analyze existing proteins, enabling it to understand the principles governing the relationship between genetic sequences and protein structure. This approach facilitates the invention of novel antibodies, peptides, enzymes, receptors, and other protein-based therapeutics optimized for specific biological functions. By harnessing its advanced technology, Generate Biomedicines aims to accelerate drug discovery by generating new biological molecules with significant therapeutic potential. Originally known as Generate Biologics, the company adopted its current name in March 2020 to reflect its expanded focus on biomedicine.
Rapport Therapeutics
Series B in 2023
Rapport Therapeutics is a clinical-stage biotechnology company dedicated to discovering and developing precision medicines for neurological disorders. The company focuses on creating transformational small-molecule therapies aimed at patients with central nervous system conditions. Leveraging foundational research in neuronal receptor biology, Rapport Therapeutics maps and targets specific neuronal receptor complexes, which are complex assemblies of proteins that include principal receptor subunits and receptor-associated proteins. These receptor-associated proteins are essential for regulating receptor expression and functionality, allowing the company to innovate in the treatment of neurological diseases.
Genesis Therapeutics
Series B in 2023
Genesis Therapeutics Inc. is a biotechnology company focused on developing small molecule drug candidates aimed at treating patients with severe and debilitating disorders. Established in 2019 and headquartered in South San Francisco, California, the company utilizes a proprietary artificial intelligence platform that integrates deep neural networks, biophysical simulation techniques, and scalable computing infrastructure. This innovative approach enhances the efficiency and accuracy of drug discovery and molecular design, allowing for improved molecular generation and property prediction. By leveraging these advanced technologies, Genesis Therapeutics seeks to transform the drug development process, ultimately aiming to optimize clinical outcomes for patients in need of effective therapies.
GenePlanet
Series B in 2023
GenePlanet is a European biotechnology company that focuses on genetic testing and research. It specializes in preventive and clinical genetic tests designed for individual users and healthcare professionals, respectively. The company's tests are developed in accordance with the highest quality standards and are rooted in current scientific knowledge. GenePlanet's offerings include saliva-based DNA tests that provide personalized insights into diet and lifestyle, enabling individuals to make informed decisions to enhance their health and mitigate potential health risks associated with genetic predispositions. Through its innovative approach, GenePlanet aims to empower individuals to improve their vitality and overall well-being with tailored prevention programs.
Moloco
Secondary Market in 2023
Moloco Inc., founded in 2013 and based in Palo Alto, California, specializes in programmatic advertising solutions aimed at optimizing client acquisition, retention, and monetization strategies. The company offers a cloud-based demand-side platform that leverages machine learning to help businesses of all sizes enhance user acquisition and maximize lifetime value through predictive models. Additionally, Moloco provides a mobile e-commerce platform that supports targeted re-engagement campaigns, allowing application publishers and e-commerce platforms to expand their customer reach more effectively than traditional advertising methods. With a team comprised of top talents from leading tech firms, Moloco is committed to empowering mobile businesses to thrive in a competitive landscape.
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.
Lightmatter
Series C in 2023
Lightmatter, Inc., established in 2017 and headquartered in Boston, Massachusetts, specializes in AI hardware development. The company pioneers integrated optical technology to create silicon chips that process data using light signals instead of electrical ones. This innovation aims to significantly accelerate AI computations, particularly in neural networks, while reducing power consumption. Lightmatter targets sectors such as artificial intelligence, cloud computing, and telecommunications.
Saluda Medical
Venture Round in 2023
Saluda Medical Pty Ltd. is a medical device company specializing in the development of neuromodulation technologies for chronic neurological conditions. Founded in 2010 and based in Artarmon, Australia, with additional offices in the United States and the United Kingdom, Saluda Medical focuses on its innovative Evoke system. This investigational device employs a closed-loop spinal cord stimulation approach that continuously monitors the spinal cord's response to stimulation and adjusts treatment in real-time to optimize patient outcomes. By utilizing a unique dose-control platform, Saluda Medical aims to customize therapy based on individual neural responses, thereby improving the management of chronic pain, particularly in patients suffering from conditions such as neuropathic pain and chronic back pain.
Shoobx
Acquisition in 2023
Financing-Ready at Every Turn. Shoobx is reshaping how private companies get started, raise capital, and exit by raising the bar for cap table management and making venture financing simpler. Everything You Need to Scale and Exit - Fundraise faster than ever before - Have more accurate data and documentation - Automate your legal operations Thousands of users, investors, and attorneys rely on Shoobx to get paperwork right the first time and make legal diligence easy and fast. Automated your next round at shoobx.com.
Asimov, Inc. is a biotechnology company based in Cambridge, Massachusetts, focused on designing and developing genetically engineered therapeutics. Founded in 2017, the company specializes in creating tools for programming living cells, utilizing a multidisciplinary approach that integrates mammalian synthetic biology, computer-aided design, and machine learning. Asimov's platform includes the development of genetic circuits for molecular manufacturing and therapeutic applications, alongside the manufacture of protein biologics, viral vectors, and cell and gene therapies. By combining synthetic biology with biophysical simulations and machine learning algorithms, Asimov aims to optimize the design and production of advanced biologics and gene therapies, thereby contributing to innovations in healthcare.
Apogee Therapeutics
Series B in 2022
Apogee Therapeutics is a San Francisco-based biotechnology company founded in 2022, specializing in the development of novel therapies for immunological and inflammatory disorders. The company focuses on creating differentiated biologics to treat conditions such as atopic dermatitis and chronic obstructive pulmonary disease, addressing significant unmet medical needs. Apogee's approach involves advancing antibody programs designed to target established mechanisms of action while utilizing advanced engineering techniques to enhance the therapeutic properties, including extended half-life. The company is actively developing two main programs: APG777 for atopic dermatitis and APG808 for chronic obstructive pulmonary disease.
Fanatics
Private Equity Round in 2022
Fanatics, Inc. is a leading global e-commerce company specializing in licensed sports merchandise, including fan gear and jerseys. Founded in 1995 and headquartered in Jacksonville, Florida, the company operates a multi-channel retail platform that serves professional sports leagues, media brands, and collegiate teams. Fanatics designs, manufactures, and distributes its products across various channels, including online, mobile, and physical stores, catering to the evolving needs of sports fans in a mobile-first, on-demand culture. The company has additional offices in San Mateo, California, and Manchester, United Kingdom, and aims to enhance the shopping experience by providing a wide range of products that meet the real-time expectations of customers.
FogPharma
Series D in 2022
FogPharma is a biotechnology company focused on developing innovative therapies for cancer treatment through its proprietary cell-penetrating mini proteins (CPMPs). Founded by Greg Verdine, a leader in drug discovery, the company aims to target cancer-causing proteins within cells that are typically inaccessible to traditional drugs. This novel approach allows for the neutralization of these proteins, potentially transforming the treatment landscape for cancer-related diseases. FogPharma collaborates with leading experts in cancer biology and therapy, fostering a network of researchers, investors, and cancer patients dedicated to advancing its mission. The company is committed to delivering this new class of medicines to improve patient outcomes and enhance quality of life for individuals affected by cancer.
Astera Labs
Series D in 2022
Astera Labs, Inc. is a fabless semiconductor company based in Santa Clara, California, specializing in purpose-built connectivity solutions for data-centric systems. Founded in 2017, the company designs and supplies high-speed mixed-signal semiconductor products, including integrated circuits and boards, to enhance PCIe connectivity. Its offerings encompass various systems such as riser cards and GPU booster cards, along with design and testing services. Astera Labs focuses on addressing performance bottlenecks in compute-intensive workloads, catering to applications in server connectivity, distributed machine learning, and high-end gaming graphics. The company collaborates with processor vendors, cloud service providers, and manufacturing partners to deliver critical connectivity performance, flexibility, and observability in its products.
Emalex Biosciences
Series D in 2022
Emalex Biosciences is a biotechnology startup focused on developing innovative treatments for central nervous system (CNS) disorders and rare neurological conditions. Founded in 2018 by Jeff Aronin, the company is advancing its lead candidate, Ecopipam, which has been explored as a potential therapy for various CNS disorders, including pediatric Tourette Syndrome and fluency disorders. Emalex aims to address the needs of patients with rare diseases that currently have limited or no treatment options, collaborating with patient advocacy organizations and medical researchers to facilitate the development of effective biopharmaceutical therapies.
SiMa Technologies, Inc. specializes in developing machine learning technology for embedded systems, offering a comprehensive machine learning system-on-chip (MLSoC) platform. Founded in 2018 and headquartered in San Jose, California, the company focuses on delivering high-performance machine learning capabilities with low power consumption. Its MLSoC enables seamless deployment and scaling of machine learning applications at the edge, enhancing performance and energy efficiency for various use cases, including computer vision and generative AI. The platform supports diverse frameworks, models, and sensors, ensuring flexibility and adaptability for customers. Additionally, SiMa's solutions incorporate security features, such as threat detection, to safeguard against potential cyber risks, thereby providing a robust environment for embedded edge applications.
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.
Wasabi Technologies, Inc. is a Boston-based company that offers a cloud storage platform tailored for hybrid and multi-cloud media workflows. Founded in 2016, Wasabi provides hot storage solutions that utilize an Amazon S3 compatible API, enabling organizations to store and access data quickly, with average time-to-first-byte speeds under 15 milliseconds. The company's platform is designed to be simple and affordable, allowing customers to access unlimited data without complex pricing tiers or unpredictable egress fees. Wasabi's services cater to various industries, including media and entertainment, education, scientific research, law enforcement, healthcare, and energy. The company has gained recognition for its rapid growth and innovative approach to cloud storage, serving tens of thousands of customers worldwide.
Galvanize Therapeutics
Series B in 2022
Galvanize Therapeutics is a medical technology company specializing in energy-based devices aimed at improving biological processes for therapeutic applications. Founded in 2022 by Apple Tree Partners, the company focuses on developing innovative solutions to treat various medical conditions, including chronic bronchitis, cardiac arrhythmias, and solid tumors. Its platform employs short-duration, high-voltage electrical pulses to create electric fields that destabilize cells through multiple biochemical mechanisms. This technology enhances the ability of medical professionals to provide effective healthcare services, positioning Galvanize Therapeutics as a potential leader in delivering cutting-edge medical innovations.
Study Plus
Series D in 2022
Study Plus is an educational application that focuses on enhancing collaborative studying among students. It operates as a learning management platform, helping users adopt a systematic approach to their studies. The platform enables students to record their study times, subjects, and content, while also allowing them to share this information through social networks. By facilitating organization and collaboration, Study Plus aims to support students in completing their syllabus efficiently and effectively.
Aledade, Inc. is a company that supports primary care physicians in establishing and managing accountable care organizations (ACOs) across the United States. Founded in 2014 and headquartered in Bethesda, Maryland, Aledade provides a comprehensive suite of services including data analytics, guided workflows, regulatory expertise, and payer relationships. The company aims to empower independent primary care providers by offering customized solutions, operational support, and advanced technology to enhance practice efficiency and patient care. Aledade serves a diverse range of healthcare practices, including small and large practices, community health centers, and multispecialty groups. By facilitating better care delivery and reducing overall costs, Aledade helps physicians maintain their independence while improving health outcomes for their patients.
SiMa Technologies, Inc. specializes in developing machine learning technology for embedded systems, offering a comprehensive machine learning system-on-chip (MLSoC) platform. Founded in 2018 and headquartered in San Jose, California, the company focuses on delivering high-performance machine learning capabilities with low power consumption. Its MLSoC enables seamless deployment and scaling of machine learning applications at the edge, enhancing performance and energy efficiency for various use cases, including computer vision and generative AI. The platform supports diverse frameworks, models, and sensors, ensuring flexibility and adaptability for customers. Additionally, SiMa's solutions incorporate security features, such as threat detection, to safeguard against potential cyber risks, thereby providing a robust environment for embedded edge applications.
Vention Inc. is a digital manufacturing platform that simplifies the design and ordering of custom machines for industrial automation. Founded in 2016 and headquartered in Montreal, Canada, the company offers a cloud-based solution that includes a 3D Machine Builder, which features an extensive library of modular components for applications such as automated equipment, robot cells, tooling, and conveyors. Vention's platform allows engineers and manufacturing professionals to design, program, simulate, and order custom factory equipment efficiently, significantly reducing the time typically required for these processes. Additionally, the integration of artificial intelligence helps streamline the design experience, making industrial automation more accessible to both experienced professionals and newcomers in the field.
X (formerly Twitter)
Post in 2022
Twitter is a social networking platform that facilitates the exchange of micro-blogs, known as "tweets," which can be up to 280 characters in length. Launched in 2006, it allows users to send and read tweets through various means, including web browsers, SMS, and mobile applications. With over 400 million monthly visitors and 255 million active users, Twitter serves as a global real-time communications platform. Its diverse user base includes world leaders, athletes, entertainers, and news organizations, contributing to its role as a significant source of information and engagement. The platform is available in more than 35 languages and has a strong presence in major cities worldwide, with headquarters in San Francisco and offices across the United States and internationally.
Castle Creek Biosciences
Venture Round in 2022
Castle Creek Biosciences, Inc. is a gene therapy company headquartered in Exton, Pennsylvania, that specializes in developing and commercializing personalized gene therapies for rare skin and connective tissue disorders. Founded in 2015, the company utilizes a fibroblast technology platform that extracts fibroblast cells from a patient's own skin to create localized therapies tailored to the individual’s unique biology. This innovative approach aims to address the underlying causes of diseases that currently have high unmet medical needs, ultimately improving the lives of patients suffering from these underserved conditions.
Starling Bank
Series D in 2022
Starling Bank Limited is a digital-only bank based in London, United Kingdom, founded in 2014. It specializes in providing personal, joint, and business banking services through a mobile platform. The bank offers a range of financial services, including digital banking, real-time spending intelligence, and personalized banking options. Customers can manage their accounts entirely online, benefiting from features such as same-day payments and comprehensive financial management tools. Starling Bank aims to facilitate a seamless, paperless banking experience for its users.
BETA Technologies
Series B in 2022
BETA Technologies is an electric aerospace company focused on developing electric aircraft and advanced flight control systems aimed at promoting clean aviation technology. The company designs a self-sufficient ecosystem of electric vertical takeoff and landing (eVTOL) aircraft that meets the transportation needs of people and goods while adhering to environmental principles. BETA's technology encompasses all-electric aircraft and a comprehensive charging infrastructure to support various electric vehicles, enhancing the efficiency and sustainability of transportation. The company also offers training programs for pilots and maintenance personnel, serving clients in cargo, passenger, and emergency response sectors, thereby enabling more efficient, cleaner, and faster transportation solutions.
Dianthus Therapeutics
Series A in 2022
Dianthus Therapeutics is a clinical-stage biotechnology company focused on developing innovative treatments for severe autoimmune diseases through targeted therapies. The company's lead candidate, DNTH103, is a monoclonal antibody designed to selectively inhibit a specific component of the immune system, offering potential advantages over existing complement therapies. This treatment aims to improve safety and efficacy for patients suffering from serious autoimmune and inflammatory conditions. Dianthus is committed to advancing its pipeline of next-generation complement therapeutics, supported by a team of experienced professionals in the biotech and pharmaceutical sectors. The company envisions that DNTH103 could be administered as a self-injection for certain patients, enhancing convenience and accessibility in treatment.
Circle
Private Equity Round in 2022
Circle is a financial technology firm established in 2013 by Jeremy Allaire and Sean Neville, headquartered in Boston, with additional offices in New York, San Francisco, Dublin, London, and Hong Kong. The company leverages blockchain technology to facilitate payments and e-commerce through stablecoins and its Circle Pay platform, streamlining the process of sending money. Circle offers a range of services, including Circle Invest, which allows users to buy and sell cryptocurrency assets, and Circle Trade, which provides over-the-counter trading services with access to one of the largest global liquidity pools for digital asset trading, averaging $2 billion in monthly volume. Backed by prominent investors such as Goldman Sachs and Accel Partners, Circle positions itself as a key player in the global internet finance sector, focused on integrating crypto assets into mainstream financial applications.
Coin Metrics
Series C in 2022
Coin Metrics Inc. is a provider of blockchain and cryptocurrency data analytics, based in Cambridge, Massachusetts. Founded in 2017, the company specializes in delivering market and network data, analytics, and research to various industries and institutions involved in crypto-assets. Its offerings include the CM Network Data Pro, which provides comprehensive historical data on top cryptocurrency assets, and the CM Market Data Feed, which standardizes trade, candle, and order book data from multiple exchanges. Additionally, Coin Metrics offers CM Reference Rates, which present fixed asset pricing in U.S. dollars. By focusing on transparency and actionable data, Coin Metrics aims to empower individuals and organizations to make informed financial decisions related to cryptocurrencies.
Rapyd
Secondary Market in 2022
Rapyd is a payments platform that integrates fintech services into applications, streamlining access to a variety of local payment methods. It empowers e-commerce merchants, gig platforms, challenger wallets, remittance services, online lenders, and traditional banks to overcome the constraints of outdated infrastructure. By facilitating the creation of innovative, mobile-friendly payment solutions, Rapyd enhances the financial capabilities of its users, allowing them to adapt to the evolving demands of the digital economy.
Starry, Inc. is an innovative internet company based in Boston, Massachusetts, with an additional operation in New York City. Founded in 2014, the company specializes in developing user-friendly Wi-Fi products and high-speed internet services. Its flagship product, Starry Station, is the first ambient touchscreen Wi-Fi router, designed to provide users with enhanced visibility and control over their home networks. In addition to its hardware, Starry employs advanced technologies to deliver high-speed broadband using hybrid-fiber fixed wireless solutions, offering gigabit-capable internet without the constraints of bundles, data caps, or long-term contracts. The company is committed to prioritizing customer needs, ensuring privacy, and promoting affordable connectivity and digital equity within communities.
LifeMine Therapeutics
Series C in 2022
LifeMine Therapeutics, Inc. is a biotechnology company focused on the genomic discovery of new drug modalities derived from eukaryotic microbes, specifically fungi. Founded in 2016 and headquartered in Cambridge, Massachusetts, with an additional office in New York, it employs an integrated drug discovery platform that combines genomics, artificial intelligence, and synthetic biology. LifeMine’s Avatar-Rx platform utilizes high-throughput microbiology, data science, genome engineering, and automation technologies to identify novel gene-encoded molecules (GEMs) with specific biological functions. The company emphasizes chemoinformatic-assisted drug optimization and advanced chemical synthesis, enabling the progression of new product candidates into development. Founded by experts in the field, LifeMine Therapeutics aims to innovate medicine through its unique approach to leveraging the fungal biosphere.
PrognomIQ
Venture Round in 2022
PrognomiQ is a technology company specializing in transforming the early detection and treatment of complex diseases like cancer. It generates comprehensive proteomic, genomic, and metabolomic data to provide insights into these conditions, aiming to enhance patient outcomes. The company's innovative approach involves developing advanced test products that improve understanding and management of health issues by integrating diverse health data types.
Menlo Micro
Series C in 2022
Menlo Micro, Inc. specializes in the design and development of electronic switches, particularly through its innovative Ideal Switch technology. This electromechanical switch is capable of handling both AC/DC and RF signals, making it suitable for a range of applications including high-power tunable resonators, filters, broadband power amplifier impedance matching, and electronically steerable antennas. The company's products are utilized in various industries, such as battery management, home automation, electronic vehicles, medical instrumentation, and the industrial Internet of Things, as well as in next generation 5G mobile networks. Founded in 2016 and headquartered in Irvine, California, Menlo Micro aims to enhance the efficiency and performance of advanced systems under high-stress conditions.
Saluda Medical
Private Equity Round in 2022
Saluda Medical Pty Ltd. is a medical device company specializing in the development of neuromodulation technologies for chronic neurological conditions. Founded in 2010 and based in Artarmon, Australia, with additional offices in the United States and the United Kingdom, Saluda Medical focuses on its innovative Evoke system. This investigational device employs a closed-loop spinal cord stimulation approach that continuously monitors the spinal cord's response to stimulation and adjusts treatment in real-time to optimize patient outcomes. By utilizing a unique dose-control platform, Saluda Medical aims to customize therapy based on individual neural responses, thereby improving the management of chronic pain, particularly in patients suffering from conditions such as neuropathic pain and chronic back pain.
Gousto
Secondary Market in 2022
Gousto is a home meal kit service that delivers fresh, organic, and seasonal ingredients along with curated recipes directly to customers' doorsteps. Founded in 2011 by Timo and James, the company addresses the challenges of meal preparation by offering an easy online platform where users can select from a weekly updated menu of recipes. Each recipe is developed by a team of chefs and tested by their friends and families to ensure quality and appeal. Gousto allows subscribers the flexibility to pause their service as needed, making it convenient for those with busy lifestyles. The company has evolved from its initial market stall offerings into a comprehensive service that simplifies the cooking process while promoting healthy eating.
Omada Health, Inc. is a digital healthcare company that specializes in developing online programs aimed at managing chronic conditions. Founded in 2011 and headquartered in San Francisco, California, with an additional office in Atlanta, Georgia, Omada focuses on preventing conditions such as prediabetes, diabetes, hypertension, and heart disease. The company provides personalized digital health programs that cater to the unique needs of individuals, utilizing professional health coaching, connected health devices, and real-time data to facilitate meaningful health improvements. Omada is recognized as the largest provider of the National Diabetes Prevention Program, empowering individuals to engage actively in their health and achieve sustainable lifestyle changes. The platform also addresses behavioral health issues, including anxiety and depression, further supporting individuals in their overall wellness journey.
Somatus, Inc. is a healthcare company focused on providing specialized kidney care services aimed at delaying or preventing the progression of chronic kidney disease. Founded in 2016 and headquartered in McLean, Virginia, Somatus collaborates with health plans, health systems, nephrology, and primary care groups to deliver integrated care for patients with or at risk of kidney disease. Its comprehensive services include home hemodialysis, peritoneal dialysis, in-center hemodialysis, kidney transplant, and conservative care. By utilizing vertically integrated clinical services and technology, Somatus seeks to improve patient outcomes, enhance care coordination, and promote the use of home dialysis modalities while increasing the rates of kidney transplantation. The company's mission is to ensure that patients can access the care they need to manage kidney disease effectively.
CelLink Corporation, founded in 2012 and headquartered in Belmont, California, specializes in the development of flexible conductive backplanes and circuits designed for power electronics. The company focuses on creating high-conductance, large-area flexible circuits that integrate multiple functionalities, including busing, fusing, and voltage and temperature monitoring. These innovations are intended for use in a variety of applications such as batteries, light-emitting diodes, wire harnessing, and solar cells, facilitating efficient power transmission. By offering these advanced circuits, CelLink aims to provide customers with affordable solutions that enhance the performance and reliability of their power-related devices.
Chenjing Tech
Series A in 2022
VR
LeddarTech
Series D in 2022
LeddarTech Inc. is a Canadian company that specializes in developing advanced detection and ranging systems, utilizing time-of-flight measurement technology with infrared LEDs. Its product offerings include smart sensor modules for various applications, such as single-element and multi-element sensor modules, LED-based traffic management sensors, and sensor evaluation kits. These solutions are designed for a wide range of applications, including advanced driver assistance systems (ADAS), autonomous driving, public safety, and industrial monitoring. LeddarTech's flagship platform, LeddarVision™, integrates multiple sensor types to create comprehensive 3D environmental models, facilitating improved perception and navigation capabilities in vehicles. The company aims to address critical sensing challenges for OEMs and automotive suppliers, helping them enhance performance while reducing development time and costs. Founded in 2007 and headquartered in Quebec City, Canada, LeddarTech maintains a research and development office in Toronto and has secured numerous patents in the field of remote sensing technologies.
MNTN Performance TV is a connected TV advertising platform that specializes in delivering measurable results for marketers through its advanced suite of targeting, measurement, and automated optimization technologies. The company develops a cloud-based advertising platform designed to enhance measurable conversions, revenue, and site visits for clients. It offers an integrated cross-device advertising system that encompasses social, mobile, and display advertising. Key features of the platform include audience segmentation, campaign management, a creative ad builder, and comprehensive reporting tools. This enables marketers and advertisers to maintain complete control and transparency over their campaigns, ensuring that their television advertising initiatives not only meet their goals but also create a lasting business impact.
Capital Markets Gateway
Series B in 2022
Capital Markets Gateway Inc. is a financial technology firm that specializes in modernizing the equity capital markets. Based in Chicago, Illinois, with additional locations in New York and Seattle, CMG offers a platform that provides real-time information and analytics to investors, underwriters, and issuers. Founded in 2015 and officially launched in 2017 by a team of experienced professionals, the platform enhances transparency and workflow efficiencies in capital raising activities. It enables users to monitor the capital raising landscape, conduct due diligence, and make informed investment decisions while facilitating collaboration between stakeholders. Currently, CMG's platform is utilized by over 100 buy-side firms and 10 investment banks, supporting a substantial amount of assets under management.
Sonder Holdings
Post in 2022
Sonder Holdings is a hospitality company that leases hotel-style apartments to travelers, offering a variety of accommodation options, including rooms, suites, and apartments. Formerly known as Flatbook Corp., the company rebranded as Sonder Canada Inc. in 2016 and operates under the name Sonder. Incorporated in 2018 and based in Montreal, Canada, Sonder provides both short and long-term stays across more than 30 cities in North America, Europe, and the Middle East. The company focuses on delivering a tech-driven, seamless experience through a user-friendly app that allows guests to access self-service features and 24/7 support. Each Sonder unit is carefully selected, designed, and managed by the company, ensuring a consistent and thoughtfully curated experience for travelers.
Bolt Technology OÜ is a transportation platform based in Tallinn, Estonia, that provides ride-hailing, micromobility, and food delivery services. Founded in 2013, Bolt operates a smartphone application that allows users to book taxis directly, selecting options based on price and quality ratings, while also tracking the driver's arrival in real time. The platform aims to enhance urban mobility by offering a reliable and accessible alternative to traditional transportation methods, contributing to reduced traffic congestion and pollution in cities. With over 50 million customers across more than 40 countries, Bolt is recognized as one of the fastest-growing startups globally, striving to create a future with less reliance on car ownership.
Oddity
Venture Round in 2022
ODDITY is a consumer-tech company that builds and scales digital-first brands to disrupt the offline-dominated beauty and wellness industries. The company owns IL MAKIAGE and SpoiledChild.
SalioGen Therapeutics
Series B in 2022
SalioGen Therapeutics is a biotechnology company focused on developing innovative gene therapies for inherited disorders. Utilizing its proprietary Exact DNA Integration Technology (EDIT) platform, the company employs mammal-derived enzymes known as Saliogase to facilitate genome engineering. This approach allows for non-viral delivery of genes of any size, offering significant advantages in manufacturing and application. SalioGen's technology aims to provide safe, durable, and affordable solutions that could transform treatment options for patients with genetic conditions, while also enhancing the efficiency of cell therapy and biologics manufacturing within the healthcare sector.
DNA Script
Series C in 2022
DNA Script is a pioneering company in the field of DNA synthesis, focused on enhancing life sciences and human health through innovative technology. It has developed the SYNTAX, the world's first benchtop DNA printer, which allows laboratories to produce synthetic oligonucleotides using a novel enzymatic process. This method employs natural enzymes for nucleic acid synthesis, enabling rapid and efficient production of critical genomic experimental precursors. By providing greater control over workflow and accelerating access to results, DNA Script supports researchers in advancing experiments and developing new therapeutics effectively.
Asoview is an online booking platform that specializes in facilitating reservations for a diverse range of tourist activities and experiences. The company's services encompass various options, including water and motorsports, sightseeing tours, horse trekking, cooking classes, and cultural activities. By providing a comprehensive and user-friendly interface, Asoview enables customers to easily discover and book activities that match their interests, streamlining the planning process for travelers and enhancing their overall experience.
EQRx, Inc. is a biotechnology company based in Cambridge, Massachusetts, established in 2019. The company focuses on re-engineering the drug discovery and delivery process to provide a market-based solution to the escalating costs of medications. EQRx aims to enhance the efficiency and affordability of high-quality, patent-protected medicines by collaborating with various stakeholders across the healthcare system and leveraging advancements in science and technology. The company has developed a robust pipeline with over ten programs, including clinical and preclinical projects targeting oncology and immune-inflammatory conditions, featuring compounds such as Aumolertinib, Lerociclib, Sugemalimab, and Nofazinlimab.
Cvent is a technology provider focused on enhancing the meetings, events, and hospitality industries through a comprehensive event marketing and management platform. The company offers software solutions that facilitate online event registration, venue selection, event marketing, and management, as well as attendee engagement for various formats, including virtual, hybrid, and onsite events. Cvent's tools are designed to help event planners and marketers optimize the revenue potential of their programs while simplifying the management of each stage in the event lifecycle. By integrating these functionalities, Cvent aims to streamline the planning process and improve overall event effectiveness.
P3 Health Partners
Post in 2021
P3 Health Partners is a patient-centered and physician-led population health management company based in Henderson, Nevada. Founded in 2017, P3 focuses on providing primary health care services through clinical operations, population health management, and consulting. The company is dedicated to enhancing patient outcomes and experiences by leveraging a coordinated network of community providers. By integrating existing healthcare resources, P3 aims to improve care delivery while reducing costs. The organization comprises a team of doctors, clinicians, and support professionals who are committed to delivering value-based care, ensuring greater satisfaction for both patients and healthcare providers.
Local Bounti is an agriculture company based in Hamilton, Montana, focused on controlled environment agriculture. Established in 2018, it specializes in producing and delivering fresh herbs, vegetables, and other products primarily to wholesale restaurant and grocery accounts. The company employs proprietary technology to cultivate leafy greens and herbs in innovative greenhouses, which maintain optimal conditions for growth while using less water and land than traditional farming methods. Local Bounti's products are non-GMO, free from herbicides and pesticides, and are designed to have a longer shelf life and superior taste. By building local facilities operated by local teams, the company aims to serve its communities while minimizing its carbon footprint and environmental impact.
Grab Holdings Inc., headquartered in Singapore, operates a mobile technology platform that integrates city transportation and various on-demand services in Southeast Asia. The company, founded in 2012 by Anthony Tan and Tan Hooi Ling, offers services such as ride-hailing (GrabTaxi, GrabCar), carpooling (GrabHitch, GrabShare), shuttle services (GrabShuttle, GrabShuttle Plus), and food delivery through its GrabFood platform. Grab also provides financial services, including payments, consumer loans, and enterprise offerings. It operates in eight countries: Singapore, Indonesia, Philippines, Malaysia, Thailand, Vietnam, and Myanmar. Grab generates revenue by charging commissions to both consumers and service providers, with ride-hailing and food delivery contributing to 89% of its total revenue. The company competes with Foodpanda and Gojek in the region.
Innovid is an independent omni-channel advertising and analytics platform designed specifically for television. The company offers a comprehensive software solution that enables advertisers to personalize, deliver, and measure innovative advertising experiences across various devices and media outlets. Its services encompass ad serving, measurement, and creative optimization for TV advertisements, catering to advertisers, publishers, and media agencies. With a strong presence in the U.S., Canada, EMEA, APAC, and LATAM, Innovid focuses on enhancing the effectiveness of TV advertising by providing tools that facilitate the creation and analysis of ads in connected TV, mobile TV, and desktop environments.
Quell Therapeutics
Series B in 2021
Quell's vision is to become a leading engineered Treg cell therapy company. The company will seek to develop next generation engineered T-regulatory cell (Treg) therapies for a range of solid organ transplant and autoimmune conditions. Quell has been founded by Syncona in partnership with six leading experts in the Treg field, cell engineering, solid organ transplantation and autoimmune diseases: Giovanna Lombardi, Professor of Human Transplant Immunology at Kings College London (KCL), Alberto Sanchez-Fueyo, Professor of Hepatology in the Institute of Liver Studies at KCL, Hans Stauss, Professor of Tumour Immunology and Director of the Institute of Immunity and Transplantation at University College London (UCL), Emma Morris, Professor of Clinical Cell & Gene Therapy and Inflammation, Immunity and Immunotherapeutics Theme Director, National Institute for Health Research University College London Hospitals Biomedical Research Centre, Marc Martinez-Llordella, Senior Lecturer in the Institute of Liver Studies at KCL and Elmar Jaeckel, Co-Leader Liver Transplant program MHH, Group Leader "Immune tolerance" in the Department of Gastroenterology, Hepatology and Endocrinology at Hannover Medical School.
GaN Systems
Venture Round in 2021
GaN Systems Inc. is a semiconductor company specializing in the development and manufacture of gallium nitride power switching transistors. Founded in 2008 and headquartered in Ottawa, Canada, the company also has offices in Japan, China, and Germany. It offers a variety of products, including 650 V and 100 V E-HEMT transistors and wireless power amplifiers, which are utilized in various applications such as consumer electronics, industrial systems, renewable energy solutions, and transportation. GaN Systems aims to address significant challenges in power systems by providing high-efficiency and compact power solutions, ultimately enabling improvements in energy efficiency and cost-effectiveness for its clients across different sectors. The company serves a diverse market, including consumer brands and enterprise equipment manufacturers in Asia and beyond.